"Interesting..."
There was no rush, so Xia Xu began leafing through some of the experimental records with interest.
He already had a fairly good grasp of the Giants Gland and Epiphysis Reactivation Technology, so he focused mainly on the sections related to Werewolf Giants and Beastmen.
Two documents were particularly interesting. One concerned the genetic encryption mechanism possessed by Beastmen.
The main reason Andra could subject Beastmen to further modification was that they possessed an inhibitory enzyme. Injecting this special inhibitory enzyme could prevent the cells of beastification-modified humans from self-destructing.
The other document was even more interesting: Andra's internal research data on the Beastmen's peculiar transformation ability.
Although Andra possessed the technology to create Beastmen, the original genetic blueprint had been obtained from an abandoned laboratory in Suwu Country. They therefore did not actually know everything about it and had been working to reverse-engineer it all along.
The most valuable aspect of Beastmen was undoubtedly this transformation ability. It could change their form and physique while strengthening their bodies. Even on its own, it was an extremely valuable technology.
This document was precisely what Gardner Organization had requested from Andra's subsidiary specializing in Beastification Technology while modifying the Werewolf Giants.
Even the name mentioned in passing on the report was interesting.
Gleipnir Biotech.
The name was both unfamiliar and familiar.
Unfamiliar, naturally, because he had never heard of this company.
Familiar because Gleipnir was precisely the name used for the control system that controlled Werewolves and Giant Test Subjects.
Gleipnir, in Western mythology, should refer to the chain that bound the giant wolf Fenrir. He had to admit that it was a fitting name for a system used to control Werewolves.
If he remembered correctly, the Werewolf Giants' actual designation at Gardner Organization was "Fenrir Prototype." The Fenrir here